CAMH presents new Microvolt T-wave Alternans testing data at Heart Rhythm Society mee
 

Cambridge Heart, Inc. a developer of non-invasive diagnostic tests for cardiac disease, today announced that new data presented at the Heart Rhythm Society's 32nd Annual Scientific Sessions in San Francisco confirm the diagnostic value of Microvolt T-wave Alternans testing in identifying patients at risk of sudden cardiac arrest.

More...